Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
107 hedge funds and large institutions have $243M invested in Surgalign Holdings, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 6 closing their positions.
23,600% more call options, than puts
Call options by funds: $237K | Put options by funds: $1K
200% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 6
51% more capital invested
Capital invested by funds: $161M → $243M (+$82.2M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
26% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 31
13% more funds holding
Funds holding: 95 → 107 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Rutabaga Capital Management
Boston,
Massachusetts
|
+$4M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$2.1M |
| 3 |
Renaissance Technologies
New York
|
+$1.41M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
+$1.19M |
| 5 |
Millennium Management
New York
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.96M |
| 2 |
2L
22NW LP
Seattle,
Washington
|
-$1.4M |
| 3 |
GS
Gagnon Securities
New York
|
-$949K |
| 4 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$924K |
| 5 |
BlackRock
New York
|
-$784K |
SRGA Hedge Fund Activity: Q2 2017 in Review
107 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2017, worth a combined $243M — up 51% from $161M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new SRGA positions and 6 closed out — a net gain of 12 holders — while 39 added to existing stakes and 31 trimmed.
The largest buyer was Rutabaga Capital Management, opening a new position worth an estimated $4M. The largest seller was Kennedy Capital Management, cutting an estimated $2.96M.
- 107 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2017, up from 95 in Q1 2017.
- Funds reported $243M of Surgalign Holdings, Inc. Common Stock stock for Q2 2017, up 51% quarter-over-quarter.
- 18 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2017 and 6 closed out, a net change of +12 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2017 was Rutabaga Capital Management, an estimated $4M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2017 was Kennedy Capital Management, an estimated $2.96M sold.
Based on aggregated 13F filings for Q2 2017.